Guardion aims to increase its existing customer base by making NutriGuard products available to patients directly and through recommendations by their physicians
Image: Guardion acquires certain assets of NutriGuard Research. Photo: Courtesy of Adam Radosavljevic from Pixabay.
Ocular health technologies and products provider Guardion Health Sciences, through its wholly-owned subsidiary, NutriGuard Formulations, has acquired definite assets from NutriGuard Research.
NutriGuard is engaged in formulating high-quality, scientifically-credible nutraceuticals, which are designed to supplement consumers’ diets and assist in treating/preventing diseases.
In addition to maintaining pharmaceutical standards to establish safety and efficacy of the products, NutriGuard is also conducting manufacturing quality assurance programmes.
Guardion founder and CEO Michael Favish said: “We believe that the NutriGuard acquisition marks just the beginning of the expansion of Guardion’s nutraceutical portfolio. This will enable us to market directly to consumers as well as to their doctors.
“We are delighted to welcome Mr. McCarty as the Director of Research of NutriGuard Formulations, Inc., and we look forward to working with him as we continue to advance the NutriGuard brand and support our doctor partners and the patients that they serve.”
The transaction offers direct-to-consumer (DTC) capability for Guardion
Guardion aims to increase its existing customer base by making NutriGuard products available to patients directly and through recommendations by their physicians.
Under the transaction, Guardion has acquired certain assets of the NutriGuard brand, including its trademarks, copyrights and other intellectual property, and has assumed liabilities of NutriGuard, replacing royalty fee the sale of NutriGuard’s brand of products.
In conjunction with the transaction, NutriGuard founding shareholder Mark McCarty has signed a consulting agreement with NutriGuard Formulations.
Under the consulting agreement, McCarty will serve as research director for NutriGuard Formulations and would provide consulting services to help Guardion integrate DTC capabilities into its operations.
McCarty said: “I am very excited about joining forces with Guardion. We are seeing increasing numbers of physicians becoming educated on the value of rational nutraceutical supplementation.
“Additionally, more and more research studies on the health benefits of nutritional supplements are being published in respected medical journals. With significant clinical data and product-specific scientific evidence now available, many doctors are looking for ways to incorporate therapeutic doses of key supplements into their patients’ standard care.”